Medicare Enrolled
Dr. Stephen Newman, M.D.
Cardiovascular Disease · Weatherford, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Newman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Newman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Newman
Dr. Stephen Newman is a cardiovascular disease specialist in Weatherford, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Newman performed 4,742 Medicare services across 3,670 unique beneficiaries.
Between the years covered by Open Payments, Dr. Newman received a total of $39,481 from 41 pharmaceutical and/or device companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Newman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in TX
$39,481 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,742
Medicare services
Top 18% in TX for cardiovascular disease
3,670
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~250 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,211 | $87 | $218 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
543 | $10 | $26 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
374 | $57 | $154 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
373 | $43 | $58 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
339 | $145 | $338 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
262 | $4 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
160 | $128 | $306 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
152 | $11 | $25 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
142 | $16 | $39 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
142 | $21 | $60 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
130 | $53 | $135 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
128 | $337 | $755 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $109 | $284 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
105 | $144 | $329 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
64 | $171 | $399 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
61 | $66 | $169 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
61 | $57 | $141 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
57 | $20 | $46 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $32 | $99 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $62 | $135 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $98 | $221 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
24 | $117 | $310 |
| New patient office visit, complex (60-74 min) | 23 | $141 | $374 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
21 | $36 | $87 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
21 | $18 | $48 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
21 | $16 | $40 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
20 | $128 | $325 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
18 | $187 | $414 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
12 | $51 | $125 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
12 | $19 | $45 |
| Continuous ECG monitoring with symptom tracking, up to 30 days This procedure involves continuous electrocardiogram monitoring for up to 30 days. It includes symptom monitoring to correlate heart activity with patient-reported events. |
11 | $6 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.5% high complexity
30.1% medium
61.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$39,481
Total received (2018-2024)
Avg $5,640/year across 7 years
Top 13% in TX for cardiovascular disease
41
Companies
679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$29,670 (75.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,811 (24.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,126
2023
$5,678
2022
$7,608
2021
$9,217
2020
$8,634
2019
$1,850
2018
$5,370
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$29,532
Novartis Pharmaceuticals Corporation
$1,667
Amarin Pharma Inc.
$788
Actelion Pharmaceuticals US, Inc.
$574
HeartFlow, Inc.
$574
Regeneron Healthcare Solutions, Inc.
$569
Boehringer Ingelheim Pharmaceuticals, Inc.
$562
AstraZeneca Pharmaceuticals LP
$561
SANOFI-AVENTIS U.S. LLC
$552
PFIZER INC.
$520
E.R. Squibb & Sons, L.L.C.
$484
Janssen Pharmaceuticals, Inc
$397
Merck Sharp & Dohme LLC
$364
Astellas Pharma US Inc
$356
Esperion Therapeutics, Inc.
$322
Alnylam Pharmaceuticals Inc.
$255
Abbott Laboratories
$193
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$163
Althera Pharmaceuticals LLC
$151
Penumbra, Inc.
$149
Merck Sharp & Dohme Corporation
$137
Gilead Sciences, Inc.
$115
Edwards Lifesciences Corporation
$55
Lexicon Pharmaceuticals, Inc.
$48
Allergan Inc.
$46
Lundbeck LLC
$40
Kiniksa Pharmaceuticals, Ltd.
$38
Boston Scientific Corporation
$30
Tactile Systems Technology Inc
$29
BOSTON SCIENTIFIC CORPORATION
$28
United Therapeutics Corporation
$25
Kiniksa Pharmaceuticals International, plc
$25
Otsuka America Pharmaceutical, Inc.
$21
Novo Nordisk Inc
$20
CVRx, Inc.
$16
Daiichi Sankyo Inc.
$15
Recor Medical Inc
$13
Medtronic Vascular, Inc.
$13
Siemens Medical Solutions USA, Inc.
$13
Impulse Dynamics (USA) Inc.
$12
Bardy Diagnostics, Inc.
$10
Top 3 companies account for 81.0% of total payments
Associated products mentioned in payments ›
ACUSON Sequoia Diagnostic Ultrasound System · ANDEXXA · Arcalyst · BRILINTA · BYSTOLIC · BYVALSON · Barostim Neo System · CAMZYOS · CARDIOMEMS · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · Corlanor · ELIQUIS · ENSITE · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · INJECTAFER · Indigo · Inpefa · JARDIANCE · LEQVIO · LEXISCAN · LINZESS · LifeVest · MULTAQ · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · Optimizer · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · Repatha · Roszet · SAMSCA · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $833 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
9
Per 100K population
5.7
County median income
$102,099
Nearest hospital
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Newman is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with speaking/promotional industry engagement in the top 13% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Newman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Newman performed 1,211 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Newman receive payments from pharmaceutical companies?
Yes. Dr. Newman received a total of $39,481 from 41 companies across 679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Newman's costs compare to other cardiologists in Weatherford?
Dr. Newman's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Newman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Weatherford
Browse cardiologists in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology